Skip to content
10-K

Annual Report

Immune Design Corp.

0001437786-19-000006

← back to feed
Filed
Mar 13, 2019 12:00 AM ET
Period of report
—
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Mar 8, 2019 48.37M sh
Capex FY 2018 · Dec 31, 2018 $390K
Capex FY 2018 · Dec 31, 2017 $428K
Capex FY 2018 · Dec 31, 2016 $133K
Cash And Equivalents FY 2018 · Dec 31, 2018 $77.94M
Cash And Equivalents FY 2018 · Dec 31, 2017 $72.45M
Cash And Equivalents restated FY 2018 · Dec 31, 2016 $39.21M
Stockholders Equity FY 2018 · Dec 31, 2018 $92.01M
Stockholders Equity FY 2018 · Dec 31, 2017 $139.21M
Stockholders Equity FY 2018 · Dec 31, 2016 $95.18M
Stockholders Equity FY 2018 · Dec 31, 2015 $108.99M
Current Liabilities FY 2018 · Dec 31, 2018 $8.85M
Current Liabilities FY 2018 · Dec 31, 2017 $14.52M
Current Assets FY 2018 · Dec 31, 2018 $100.23M
Current Assets FY 2018 · Dec 31, 2017 $153.14M
Total Assets FY 2018 · Dec 31, 2018 $100.96M
Total Assets FY 2018 · Dec 31, 2017 $153.83M
Sga Expense FY 2018 · Dec 31, 2018 $15.4M
Sga Expense FY 2018 · Dec 31, 2017 $16.25M
Sga Expense FY 2018 · Dec 31, 2016 $21.86M
Rd Expense FY 2018 · Dec 31, 2018 $42.42M
Rd Expense FY 2018 · Dec 31, 2017 $43.67M
Rd Expense FY 2018 · Dec 31, 2016 $45.13M
Net Income FY 2018 · Dec 31, 2018 −$54.76M
Net Income FY 2018 · Dec 31, 2017 −$51.86M
Net Income FY 2018 · Dec 31, 2016 −$53.53M
Operating Income FY 2018 · Dec 31, 2018 −$57.05M
Operating Income FY 2018 · Dec 31, 2017 −$52.81M
Operating Income FY 2018 · Dec 31, 2016 −$54.21M
Revenue FY 2018 · Dec 31, 2018 $476K
Revenue FY 2018 · Sep 30, 2018 $462K
Revenue FY 2018 · Jun 30, 2018 $755K
Revenue FY 2018 · Mar 31, 2018 $503K
Revenue FY 2018 · Dec 31, 2017 $485K
Revenue FY 2018 · Sep 30, 2017 $516K
Revenue FY 2018 · Jun 30, 2017 $729K
Revenue FY 2018 · Mar 31, 2017 $5.47M